这一类新型药物被称为分子靶向治疗药物(molecular targeted therapeutic drugs，MTTD)。以伊马替尼和美罗华为代表的MTTD分别在慢性粒细胞性白血病(CML)和非霍杰金氏淋巴瘤(NHL)的...
基于4个网页-相关网页
然而，在临床中，仍有近三成的病人使用了目前国际上最先进的分子靶向治疗药物却没有效果。
However, in clinical practice, there are still Jinsan Cheng patients to use the current world's most advanced molecular targeted therapies have no effect.
Lapatinib是一种分子药物市场蓬勃发展的产品——被设计用来靶向治疗与疾病相关的特定的蛋白质分子。
Lapatinib is a product of the growing field of molecular medicine-the design of drugs to attack specific protein molecules associated with particular diseases.
虽然IPA - 3本身可能不适合人类使用的药物，但这种分子可以形成一个新的靶向治疗的理论基础。
While IPA-3 itself might not be a suitable as a drug for use in humans, the molecule could form the conceptual basis of a new targeted therapeutic.
应用推荐